Related Experiment Video
Updated: Jan 5, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Emerging drugs for the treatment of onychomycosis
Aditya K Gupta1,2, Nadia Stec1
1Mediprobe Research Inc, London, Ontario, Canada.
Abstract:
Introduction: Onychomycosis is a widespread nail disease, often occurring on the feet. It is a chronic and often recurring disease, which makes it difficult to eradicate. The infection may be caused by dermatophytes, non-dermatophyte molds, and yeasts. Traditionally, systemic antifungal medications have been used to treat this infection, but in recent years topical formulations have been the focus of research.Areas covered: This review outlines the current antifungal market and novel treatments currently in development or in experimental phases. It highlights a shift from systemic treatments to topical options as well as penetration enhancers. There are also several novel systemic options in development.Expert opinion: Although there have been significant developments in treatment options for onychomycosis, it remains a challenging chronic condition with less than desirable cure rates. This may be attributed to the formation of fungal biofilms and limited understanding of the fungal lifecycle. However, when patients adhere to treatment protocols and employ preventative measures, outcomes are generally favorable.
Insights
Onychomycosis, a persistent nail fungal infection, presents treatment challenges. Emerging topical therapies and improved patient adherence offer better outcomes for this common condition.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Onychomycosis is a prevalent, chronic, and recurrent nail fungal infection.
- Caused by dermatophytes, molds, and yeasts, it traditionally requires systemic antifungal treatment.
- Recent research focuses on topical formulations due to challenges with systemic therapies.
Purpose of the Study:
- To review the current market for onychomycosis antifungal treatments.
- To explore novel treatments in development or experimental phases.
- To highlight the trend towards topical options and penetration enhancers.
Main Methods:
- Literature review of current and emerging onychomycosis treatments.
- Analysis of market trends and research in antifungal therapies.
- Examination of systemic and topical treatment approaches.
Main Results:
- The antifungal market includes established systemic options and developing topical formulations.
- Penetration enhancers are being investigated to improve topical treatment efficacy.
- Novel systemic treatments are also under development.
Conclusions:
- Despite advancements, onychomycosis remains difficult to cure due to fungal biofilms and incomplete understanding of the fungal lifecycle.
- High cure rates are achievable with patient adherence to treatment and preventative measures.
- The shift towards topical treatments and novel systemic options shows promise.
More Related Videos
09:06Author Spotlight: Photodynamic Therapy as a Novel Approach to Induce Petite Colonies in Drug-Resistant Candida for Antifungal Research
Published on: March 29, 2024
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Fungal Phylum Microsporidia
Hand hygiene
Hand washing...
Fungal Group Zygomycota